NEW YORK – Lucira Health is aiming to change the way infectious disease is diagnosed in the US by empowering patients to perform accurate testing at home. The company was the first to obtain Emergency Use Authorization for a home-use molecular diagnostic for SARS-CoV-2 and is now scaling up manufacturing and positioning itself for future applications, all while emphasizing a consumer-friendly approach.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
Try GenomeWeb Premium now.
You may already have institutional access!
Check if I qualify.
Already a GenomeWeb or 360Dx Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.